Skip to main content
SpringerLink
Log in

Amiodarone and implantable cardioverter-defibrillators in congestive heart failure

  • Published:
Zeitschrift für Kardiologie Aims and scope Submit manuscript

Summary

Sudden death accounts for a significant proportion of all death in patients with heart failure. Of currently available therapy, amiodarone and the implantable defibrillator (ICD) appear to have the greatest potential to reduce sudden death in heart failure. In this paper, the currently available information on the relative role of amiodarone and implantable defibrillators (ICD) in heart failure is reviewed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Author information

Authors and Affiliations

  1. Universitätsklinik Münster, Medizinische Klinik C, D-48129 Münster, Germany, Email: bockerd@uni-muenster.de, Germany

    D. Böcker, M. Block, W. Haverkamp & G. Breithardt

Authors
  1. D. Böcker
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M. Block
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. W. Haverkamp
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. G. Breithardt
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Böcker, D., Block, M., Haverkamp, W. et al. Amiodarone and implantable cardioverter-defibrillators in congestive heart failure. Z Kardiol 88 (Suppl 3), S036–S039 (1999). https://doi.org/10.1007/s003920050586

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s003920050586

Search

Navigation